# Peramivir

## Rapiacta 300mg/60mL Drip Infusion

| TAH Drug Code      | [IRAPI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IRAPI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of acute, influenza A or B in adults                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Administer Rapiacta within 2 days of onset of symptoms of influenza. Adult: a single 300-600 mg dose IV infused over 15 minutes. Children > 1 month: a single dose of 10 mg/kg IV infused over 15 minutes (do not exceed 600 mg/dose).                                                                                                                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Serious hypersensitivity or anaphylaxis to peramivir or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Adverse Effects    | Cardiovascular: Hypertension Central nervous system: Insomnia Endocrine: Increased serum glucose Gastrointestinal: Constipation, diarrhea, vomiting (children & adolescents) Genitourinary: Proteinuria (children & adolescents) Hematologic and oncologic: Neutropenia Hepatic: Increased serum ALT, increased serum AST Neuromuscular & skeletal: Increased creatine phosphokinase Miscellaneous: Fever (children & adolescents) Rare but important or life-threatening: Abnormal behavior, anaphylactoid reaction, anaphylaxis, delirium, erythema multiforme, exfoliative dermatitis, hallucination, skin rash, Stevens-Johnson syndrome |
| Pregnancy          | Compatible â€“ Maternal Benefit >> Embryo-Fetal Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/peramivir-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

